Farmacia Hospitalaria (Jan 2015)

http://www.aulamedica.es/fh/pdf/8547.pdf

  • Rosa María Damas Fuentes,
  • Moisés Pérez León,
  • Marta Piñero González,
  • Nayra Sangil Monroy,
  • Rafael Molero Gómez,
  • Pablo Domínguez Lantigua

DOI
https://doi.org/10.7399/fh.2015.39.1.7642
Journal volume & issue
Vol. 39, no. 1
pp. 44 – 58

Abstract

Read online

Objetive: To analyze the latex content of drugs in hospital formulary and establish possible therapeutic alternatives. Methods: All drugs susceptible of having latex were selected and written information was obtained from manufacturers. A therapeutic alternative was found for each of them, if possible. Results: Written information from manufacturer was obtained for 605 (97.9%) and from label information for 8 of 632 selected drugs. For 43.9% of not safe drugs (total 57) on patients with latex allergy, a therapeutic alternative was found in hospital formulary. Conclusions: Knowing drugs having latex improve the prescription security, while the therapeutic alternatives chart eases the validation. The published data updates the scarce and variable information for patients and healthcare professionals.

Keywords